9132
Y. Arroyo et al. / Tetrahedron Letters 43 (2002) 9129–9132
1
Scarpati, R.; Graziano, M. L. Synthesis 1995, 439–443;
(f) Onitsuka, S.; Nishino, H.; Kurosawa, K. Tetrahedron
2001, 57, 6003–6009.
m/z (%) 302/300 (44/46, M+). Compound 10: H NMR:
2.30 (s, 3H, CH3ꢀC6H4ꢀ), 6.37 (d, 1H, J 2.1 Hz, H-4),
7.25–7.28 (m, 9H, H-arom); 7.52 (d, 1H, H-5); 13C NMR:
21.0 (CH3–C6H4–), 115.3 (C-4), 125.6 (C-3), 126.7, 128.5,
129.1, 129.8, 130.1 (CH-arom), 131.4, 135.1, 136.9 (C-
arom), 144.6, 146.1 (C-2, C-5); MS: m/z (%) 298 (100,
M+).
6. (a) Ba´n˜ez, J. M.; Galisteo, D.; Lo´pez Sastre, J. A.;
Rodr´ıguez Amo, J. F.; Romero, C.; Santos, M.; Sanz
Tejedor, M. A. Carbohydr. Res. 1996, 179–188; (b)
Arroyo, Y.; Carren˜o, M. C.; Garc´ıa-Ruano, J. L.;
Rodr´ıguez, J. F.; Santos, M.; Sanz-Tejedor, M. A. Tetra-
hedron: Asymmetry 2000, 11, 1183–1191.
7. (a) Chen, Ch.-Y.; Hart, D. J. J. Org. Chem. 1993, 58,
3840–3849; (b) Hart, D. J.; Wu, W.-L.; Kozikowski, A.
P. J. Org. Chem. 1997, 62, 5023–5033; (c) Hart, D. J.; Li,
J.; Wu, W.-L. J. Am. Chem. Soc. 1995, 117, 9369–9371;
(d) Byeon, Ch.-H.; Chen, Ch.-Y; Ellis, D. A.; Hart, D. J.;
Li, J. Synlett 1998, 596–598.
8. (a) Lin, Ch.; Huang, F.-J.; Lin, J.; Wu, H.-J. J. Chinese
Chem. Soc. 1996, 43, 177–186; (b) Tsai, S.-H.; Chung,
W.-S.; Wu, H.-J. J. Chinese Chem. Soc. 1996, 43, 281–
288; (c) Wu, H.-J.; Tsai, S.-H.; Chung, W.-S. Tetrahedron
Lett. 1996, 37, 8209–8212.
13. Sensitized photooxygenation reactions were carried out in
anhydrous methanol as solvent, at −40°C, with bubbling
oxygen and in the presence of methylene blue (MB) as
photosensitizer (4×10−3 mmol), under irradiation with a
500 W tungsten lamp. When each reaction was complete,
the solution was degassed at rt by bubbling with Argon.
For furans 5 and 10, Me2S (2 equiv.) in CCl4 was added
to each solution just after irradiation. The solvent was
removed on a rotatory evaporator and each residue was
washed with hexane (for 6, 7, and 9) or water (for 5, 8
and 10) and extracted with Cl2CH2.
14. Compounds 11–17 were characterized from the crude
reaction mixture on the basis of their 1H NMR (l in
ppm, CDCl3, 300 MHz), 13C NMR (l in ppm, CDCl3, 75
MHz), IR and MS spectral data.
9. Byeon, Ch.-H.; Hart, D. J.; Lai, Ch.-S.; Unch, J. Synlett
2000, 119–121.
10. The synthesis of 1 was achieved from 2,3-dibromo-2-
buten-1,4-diol by the one-pot procedure previously
described by Rewicky et al. Gorzynsky, M.; Rewicki, D.
Liebigs Ann Chem. 1986, 625–637.
11. (a) Davies, G. M.; Davies, P. S. Tetrahedron Lett. 1972,
3507–3508; (b) Danso-Danquah, R. E.; Scott, A. I. Tet-
rahedron 1993, 49, 8195–8210; (c) Alva´rez-Ibarra, C.;
Quiroga, M. L.; Toledano, E. Tetrahedron 1996, 52,
4065–4078.
1
Compound 11: H NMR: 3.85 (s, 3H, CH3O), 7.13–7.32
(m, 5H, H-arom); 13C NMR: 53.9 (CH3O), 127.1, 127.4,
129.0 (CH-arom), 131.1, 133.0 (C-2, C-3), 137.0 (C-
arom), 165.1 (COOMe), 186.2 (COSPh); IR (KBr) w
(cm−1): 1741, 1730; MS: m/z (%) 382/380/378 (1/5/1, M+).
Compound 12: 1H NMR: 3.89 (s, 3H, CH3O), 6.53 (s,
1H, H-2), 7.17–7.47 (m, 5H, H-arom); 13C NMR: 53.8
(CH3O), 126.0, 129.8 (C-2, C-3), 127.2, 127.5, 129.1 (CH-
arom), 137.0 (C-arom), 164.2 (COOMe), 193.1 (COSPh);
IR (KBr) w (cm−1): 1719, 1700; MS: m/z (%) 302/300 (3/1,
12. All new 2-thiofurans were characterized on the basis of
1
their H NMR (l in ppm, CDCl3, 300 MHz), 13C NMR
M+). Compound 13: H NMR: 3.81 (s, 3H, CH3O), 6.66
1
(l in ppm, CDCl3, 75 MHz) and MS spectral data.
1
Compound 3: mp 66–67°C (hexane); H NMR: 7.24–7.28
(s, 1H, H-3), 7.17–7.47 (m, 5H, H-arom). Compound 14:
1H NMR: 2.48 (s, 3H, SCH3), 3.88 (s, 3H, CH3O), 6.51
(s, 1H, H-2); 13C NMR: 12.6 (SCH3), 53.6 (CH3O), 125.1,
129.6 (C-2, C-3), 164.1 (COOMe), 186.9 (COSMe); IR
(KBr) n (cm−1): 1727, 1668; MS: m/z (%) 209/207 (45/43,
M+–OMe). Compound 15: 1H NMR: 2.47, 2.39 (two s,
3H, SCH3), 6.67 (s, 1H, H-3); 13C NMR: 12.0, 12.4
(SCH3), 125.8, 129.5 (C-2, C-3); 186.9, 190.1 (COSMe).
Compound 16: (E)-isomer: 1H NMR: 2.43 (s, 3H, SCH3),
6.65 (d, 1H, J 6.5, H-3), 9.94 (d, 1H, CHO); 13C NMR:
13.8 (SCH3), 137.2, 137.6 (C-2, C-3), 188.6, 189.3 (CHO,
(m, 5H, H-arom), 7.44 (s, 1H, H-5); 13C-NMR: 104.0,
114.0 (C-3, C-4), 127.6, 129.3, 129.5 (CH-arom), 132.9
(C-arom), 141.6, 147.1 (C-5, C-2); MS: m/z (%) 336/334/
332 (48/100/51, M+). Compound 4: mp 25°C (hexane); 1H
NMR: 6.55 (d, 1H, J 2.1 Hz, H-4), 7.18–7.29 (m, 5H,
H-arom), 7.5 (d, 1H, H-5); 13C NMR: 110.6 (C-3), 115.5
(C-4), 126.8, 128.2, 129.2 (CH-arom), 134.5 (C-arom)
142.9, 146.4 (C-5, C-2); MS: m/z (%) 256/254 (74/76,
M+). Compound 5: 1H NMR: 2.37 (s, 3H, SCH3), 6.44
(d, 1H, J 2.2 Hz, H-4), 7.41 (d, 1H, H-5); 13C NMR: 17.9
(SCH3), 106.2 (C-3), 115.0 (C-4), 144.9, 145.6 (C-5, C-2);
MS: m/z (%) 194/192 (48/51 M+). Compound 6: mp
77–78°C (hexane); 1H NMR: 7.26–7.28 (m, 10H, H-
arom); 13C NMR: 113.0 (C-3, C-4), 127.6, 129.3, 129.5
(CH-arom), 132.9 (C-arom), 147.0 (C-2, C-5). MS: m/z
(%) 444/442/440 (4/9/3 M+). Compound 7: mp 77–78°C
(hexane); 1H NMR: 6.73 (s, 1H, H-4), 7.19–7.25 (m, 10H,
H-arom); 13C NMR: 110.9 (C-3), 122.2 (C-4), 127.1,
127.3, 129.2 (CH-arom), 133.4 (C-arom), 146.4, 148.5
(C-2, C-5); MS: m/z (%) 364/362 (35/32, M+). Compound
1
COSMe). (Z) Isomer: H NMR: 2.42 (s, 3H, SCH3), 7.19
(d, 1H, J 6.5, H-3), 10.00 (d, 1H, CHO); 13C NMR: 13.8
(SCH3), 130.8, 136.5 (C-2, C-3), 188.7 and 192.2 (CHO,
COSMe); IR (KBr) n (cm−1): 1726, 1685; MS: m/z (%)
210/208 (17/17, M+). Compound 17: 1H NMR: 2.31 (s,
3H, CH3–C6H4–), 5.34 (d, 1H, J 3.5 Hz, H-4), 6.42 (d,
1H, H-5), 7.08–7.53 (m, 9H, H-arom); 13C NMR: 21.2
(CH3-C6H4–), 111.9 (C-5), 126.9 (C-4), 127.2, 128.9,
129.7, 136.5, 136.6 (CH-arom), 134.2 (C-3), 135.4, 140.6,
141.9 (C-arom), 164.9 (C-2); IR (KBr) w (cm−1): 1790,
1767; MS: m/z (%) 314 (4%, M+).
1
8: H NMR: 2.42, 2.44 (two s, each 3H, SCH3), 6.44 (s,
1H, H-4); 13C NMR: 18.1 (SCH3), 106.8 (C-3), 117.6
(C-4), 147.5, 150.6 (C-2, C-5); MS: m/z (%) 240/238 (3/1,
M+). Compound 9: 1H NMR: 2.42 (s, 3H, SCH3), 6.72 (s,
1H, H-4), 7.22–7.32 (m, 5H, H-arom); 13C NMR: 17.6
(SCH3), 105.8 (C-3), 122.7 (C-4), 127.5, 128.6, 129.2
(CH-arom), 133.8, 134.6 (C-arom, C-2), 146.3 (C-5); MS:
15. There are several reports in which endoperoxides rear-
ranged to give butyrolactones. See Ref. 4a, 5a and (a)
Waldemar, A.; Schuhmann, R. M. Liebigs Ann. 1996,
635–640; (b) Freeman-Cook, K. D.; Halcomb, R. L.
Tetrahedron Lett. 1998, 39, 8567–8570.